Mouse study could provide foundation for future human therapeutics
Supplementing a single protein found in the spinal cord could help prevent symptoms of Lou Gehrig’s disease, according to a new study out of Case Western Reserve University School of Medicine. Researchers found high levels of the protein—called mitofusion 2 or Mfn2—prevented nerve degeneration, muscle atrophy, and paralysis in a mouse model of the disease. Since Mfn2 is often depleted during Lou Gehrig’s, the new study suggests supplementing it could be a novel therapeutic approach for the disease.
Lou Gehrig’s disease, or amyloid lateral sclerosis (ALS), is a progressive disorder that devastates motor nerve cells. People with ALS slowly lose the ability to control muscle movement, and are ultimately unable to speak, eat, move, or breathe. The cellular mechanisms behind ALS are also found in certain types of dementia. For the estimated 15,000 Americans living with ALS, the findings offer new hope for ways to delay symptoms.
“We found a way to alleviate age and ALS-related muscular atrophy in our mouse models,” said Xinglong Wang, PhD, associate professor of pathology at Case Western Reserve University School of Medicine. “Amazingly, we could delay ALS symptom onset by 67 days.”
Wang led the study, recently published in Cell Metabolism, in which researchers successfully staved off muscle atrophy and paralysis simply by increasing Mfn2 levels in mouse spinal cords.
Wang and colleagues tested the most widely used ALS mouse model. They genetically engineered the diseased mice to have increased Mfn2 levels—but only in nerve cells that extend from the spinal cord and connect to muscle fibers. In late stages of the disease, mice with high Mfn2 levels in these nerves were a healthy weight, and did not have any of the muscle atrophy, gait abnormalities, or reduced grip strength that mice in control groups developed. Even mice who underwent heavy sciatic nerve damage benefited from elevated Mfn2 levels.
Said Wang, “Upregulation of Mfn2 specifically in nerve cells is sufficient to abolish skeletal muscle loss in ALS and aged mice, despite ALS-causing protein being found in all organs and tissues.”
By studying nerve cells collected from the mice, Wang’s team uncovered how Mfn2 offers its protective effects. The researchers found Mfn2 coexists with nutrients in cell structures called mitochondria. Their experiments showed mitochondria travel along nerve cell extensions—axons—and deliver the nutrients to the point where nerve cells and muscle fibers meet. This preserves sensitive connections—synapses—between nerve and muscle cells and prevents muscle atrophy. “We found mitochondria function as miniature ‘trucks’ to transport protein along axons to prevent synaptic degeneration,” explained Wang.
Cellular transport is not typically in the job description for mitochondria. The ancient cellular structures are well-known to be “powerhouses of the cell”—producing energy that keeps cells running. According to Wang, “this is a novel, previously unrecognized role for mitochondria.”
Specifically, Wang’s team found mitochondria use Mfn2 on their surfaces to carry a nutrient called calpstatin. Calpstatin inhibits harmful enzymes that break down nerves and muscle fibers. With the help of Mfn2, mitochondria carry calpstatin along nerve cells axons to meet muscle cells. There, calpstatin prevents enzymes from destroying delicate synapse connections. But without Mfn2, mitochondria can’t carry the nutrient.
According to Wang, the findings have broad implications. “Mfn2 deficiency or mutations are commonly observed in patients with ALS, peripheral neuropathy, Alzheimer’s disease, and other neurodegenerative diseases in which synaptic loss has long been recognized as a prominent early feature,” he says. “Supplementing Mfn2 may be a common and effective therapeutic approach to treat a wide range of diseases including but not limited muscular disorders, patients with nerve injury and various major neurodegenerative diseases associated with synaptic loss.”
The Latest on: Lou Gehrig’s Disease
via Google News
The Latest on: Lou Gehrig’s Disease
- Lorrie Swancutt -- Rochesteron March 21, 2020 at 2:00 am
Lorrie was diagnosed on April 25, 2018, with bulbar onset amyotrophic lateral sclerosis (ALS, aka Lou Gehrig's disease), a fast progression of the disease. Lorrie fought this most terrible illness ...
- Researchers’ nanodisk could restore function for Lou Gehrig’s disease patientson March 20, 2020 at 5:00 pm
Dec. 5, 2019 — For decades the renowned English physicist Stephen Hawking lived with a motor neuron disease until his death last year. People who suffer from this condition lose functionality of brain ...
- Brain Implant Allows Paralyzed Woman to Spell Out Messages With Her Mindon March 19, 2020 at 5:20 am
The new system was tested on Hanneke De Bruijne, a 58-year-old woman in the late stages of Lou Gehrig’s disease, also known as amyotrophic lateral sclerosis (ALS). Unable to move any part of her ...
- Head Trauma Linked to ALS-Like Diseaseon March 16, 2020 at 5:00 pm
The researchers have now found a link between repetitive head trauma and a new form of motor neuron disease similar to amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease. Their findings were ...
- Lou Gehrig's diseaseon March 16, 2020 at 5:00 pm
Adeona Names New Managers, Eyes Name ChangeAdeona Pharmaceuticals Inc. has swapped bosses as it continues testing new drugs for multiple sclerosis, fibromyalgia and Lou Gehrig's disease.
- Living with ALS – Providing support to caregiverson March 16, 2020 at 9:10 am
This month we are profiling the lives of people living with ALS, also known as Lou Gehrig’s disease. It’s a progressive neuro-muscular condition. It has no known cure and the cause remains a ...
- Shake it Off: An Integrative Approach to Parkinson's Solutionson March 15, 2020 at 9:34 pm
muscular dystrophy and Lou Gehrig's disease (or Amyotrophic Lateral Sclerosis). Greg Eckel, ND, a naturopathic physician, joined us to share his unique approach to treating for Parkinson's Disease ...
- Jersey Proud: Fundraiser for former Byram detective with Lou Gehrig's diseaseon March 14, 2020 at 9:39 am
The community is rallying for a former Byram police detective who has Lou Gehrig's disease. A GoFundMe has been set up to help pay for Detective Todd Duffy’s medication. Gov. Andrew Cuomo says the ...
- Donna Britt inducted into LAB Hall of Fameon March 10, 2020 at 1:03 pm
She was diagnosed with ALS, also known as Lou Gehrig’s disease, in 2016. Donna used a computerized device to deliver her prepared acceptance speech. The device allows Britt to use her eyes to ...
via Bing News